Financials
Financial year 2025
PHARMACIE HAEGEMAN from Châtelet, company number BE0551940391, closed financial year 2025 with a result of € 540,228 after tax. For that financial year PHARMACIE HAEGEMAN recorded a gross margin of € 703,024 and equity of € 700,877. Compared with financial year 2024, the result moved from € 82,644 to € 540,228. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 700,877
▲ € 540,228 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 540,228
▲ € 457,584 vs 2024
Profit after tax over the fiscal year.
€ 132,777
▼ 58% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 694,677.
People and assets in 2025
0
▼ 5 vs 2024
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
€ 63,754
▼ 54% vs 2024
Loans from banks and other lenders, long and short.
€ 7,345
▼ 86% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 410,478 | € 431,153 | € 413,760 | € 703,024 | ▲ 70% |
| Profit after taxes | € 70,078 | € 47,196 | € 82,644 | € 540,228 | ▲ € 457,584 |
| Equity | € 30,809 | € 78,005 | € 160,649 | € 700,877 | ▲ € 540,228 |
| Total debts | € 734,461 | € 619,386 | € 605,077 | € 344,913 | ▼ 43% |
| Cash | € 227,242 | € 313,106 | € 318,566 | € 132,777 | ▼ 58% |
| Land & buildings | € 13,733 | € 5,993 | € 16,085 | € 13,547 | ▼ 16% |
| Retained profit | € 24,609 | € 71,805 | € 154,449 | € 694,677 | ▲ € 540,228 |
| Bank debt | € 287,450 | € 213,883 | € 139,322 | € 63,754 | ▼ 54% |
| Balance sheet total | € 765,270 | € 697,391 | € 765,725 | € 1,220,790 | ▲ 59% |
| Employees (FTE) | 4.4 | 4.9 | 5 | 0 | ▼ 5 |
Key figures of PHARMACIE HAEGEMAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE HAEGEMAN?
What happened at PHARMACIE HAEGEMAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 540,228 (▲ € 457,584 vs 2024). filed late Source: NBB ↗
- PHARMACIE FOCH became a director. NBB
- New establishment in Châtelet. KBO
- Start of the company according to the CBE. KBO
In short
From € 70,078 profit in 2022 to € 540,228 profit in 2025.
Paid € 64,334 in corporate taxes since 2022.
Best year ever: 2025, with € 540,228 profit.
On average € 82,800 of value added per employee in 2024.
Management
Behind PHARMACIE HAEGEMAN is PHARMACIE FOCH. The shares are held by PHARMACIE ANTOINE (50%) and PHARMACIE FOCH (50%).
Directors
According to the 2025 annual accounts
since 2015
Shareholders
PHARMACIE ANTOINE · holding of PHARMACIE FOCH
50%
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Place Wilson 138
6200 Châtelet
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0551.940.391
- VAT number
- BE 0551.940.391
- Registered office
- Place Wilson 138, 6200 Châtelet
- Names & denominations
- PHARMACIE HAEGEMAN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 May 2014
- Peppol
- Active · Active since 8 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Vervaardiging van geneesmiddelen
Groothandel in farmaceutische en medische artikelen